GeoVax Labs (GOVX) Other Operating Expenses (2013)
GeoVax Labs (GOVX) posted quarterly Other Operating Expenses of -$19617.0 for Q2 2013, up 91.02% quarter-over-quarter from -$218551.0 in Q1 2013.
GeoVax Labs (GOVX) Other Operating Expenses (2013) Analysis & Trends
GeoVax Labs (GOVX) has reported Other Operating Expenses for 1 consecutive years, with -$19617.0 the latest figure, recorded in Q2 2013.
- In Q2 2013, Other Operating Expenses changed N/A year-over-year to -$19617.0; the TTM figure through Mar 2014 stood at -$19617.0 (up 91.02% YoY), while the FY2011 annual figure was -$152126.0, changed N/A from the prior year.
- Other Operating Expenses improved to -$19617.0 in Q2 2013 per GOVX's latest filing, from -$218551.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$19617.0 in Q2 2013 and bottomed at -$218551.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | -19,617.00 |
| Mar 31, 2013 | -218,551.00 |